Left Menu
Development News Edition

AFT and SETEK sign MoU to work together in R&D of medicinal cannabis

Earlier this year SETEK became the fourth New Zealand company to receive a license from the Ministry of Health to cultivate cannabis for scientific and medical research.

Devdiscourse News Desk | New Delhi | Updated: 08-10-2019 08:03 IST | Created: 08-10-2019 08:03 IST
AFT and SETEK sign MoU to work together in R&D of medicinal cannabis
Commercial arrangements between AFT and Setek will be agreed as part of any contract that emerges from the MoU. Image Credit: Pixabay

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) and New Zealand medicinal cannabis company SETEK today announce they have signed a memorandum of understanding (MoU) to work together in the research, development, and commercialization of medicinal cannabis products.

The MoU seeks to combine and take advantage of, AFT's expertise in pharmaceutical development, commercialization and distribution and SETEK's expertise in cannabis cultivation and the extraction and processing of pharmaceutical-grade cannabis compounds.

Earlier this year SETEK became the fourth New Zealand company to receive a license from the Ministry of Health to cultivate cannabis for scientific and medical research. It is developing a 100% organic cannabis propagation, cultivation, processing, and manufacturing facility at Rotokawa, near Taupo.

AFT Pharmaceuticals Chief Executive Dr. Hartley Atkinson said: "Medicinal cannabis represents a sunrise industry in New Zealand and is an obvious addition to our broad portfolio of prescription and over the counter medicines.

"SETEK is on track to become a leading New Zealand producer of medical cannabis and cannabis extracts. It has recently acquired a cannabis genetics company and is working towards the construction of a new, state-of-the-art medical cannabis facility that is due to commence production next year.

"These assets coupled with AFT's expertise in the commercialization and distribution of pharmaceuticals have the potential to create a winning combination in New Zealand's emerging medicinal cannabis sector."

SETEK Chief Executive Mark Mees said: "We are delighted to have reached this cooperation agreement with AFT. Hartley and his team are recognized internationally for their capabilities in taking medicines through clinical trials, regulatory approvals and then successfully distributing and selling these products in New Zealand, Australia and further afield.

"This agreement envisages SETEK and AFT each playing to their strengths. We are looking forward immensely to working with AFT to bring our shared vision to life."

The MoU envisages the two companies jointly:

• developing business models for the development, manufacture, formulation and obtaining regulatory approval (if applicable) for selling, marketing, and distribution of products;

• endeavoring to discover new medicinal cannabis opportunities;

• sharing expertise, experience, and know-how; and

• cooperating in other areas of common interest.

It also envisages SETEK managing the propagation, cultivation, extraction, processing, and manufacture of any medicinal cannabis products emerging from the collaboration. It will also be the exclusive supplier of these products to AFT.

AFT will meanwhile conduct any clinical trials and manage regulatory approvals of any product and will be granted an exclusive right to sales, marketing and distribution of the medicinal cannabis products in Australia and New Zealand. It will also be granted the right of first refusal to do the same in other territories around the world.

Commercial arrangements between AFT and Setek will be agreed as part of any contract that emerges from the MoU.


TRENDING

OPINION / BLOG / INTERVIEW

Uganda COVID-19 response: Was off to a good start but reopening dwindled prospects

Uganda has shown success in using health information to enhance efficiency of disease surveillance, reporting and monitoring. The success, however, has critical challenges confronting it as the country resumes normal activities....

New farm bills in India: Focusing on farms or farmers?

... ...

Kenya’s COVID-19 response: Chaos amid lack of information

Confusing numbers and scanty information on how effective curfews and lockdowns have been in breaking transmission have amplified coordination and planning challenges in Kenyas response to COVID-19. Without accurate data, it is impossible t...

Farkhad Akhmedov: Calculating the price of impunity from the law

In insistences such as the battle over the Luna, Akhmedov has resorted to extreme legal machinations to subvert the High Courts decision and keep his assets from being seized. ...

Videos

Latest News

India, US working closely in Defence, Foreign policy has larger resonance: Jaishankar

External Affairs Minister S Jaishankar said that the ability of India and the US to work closely in defence and foreign policy matters has a larger resonance. At a time when it is particularly important to uphold a rules-based international...

Customs seizes 435 grams of compound gold at Kozhikode Airport

The Customs officials at Kozhikode International Airport have seized 435.5 grams of compound gold from a passenger who arrived from Dubai, the Commissionerate of Customs Preventive said on Tuesday.According to officials, the compound gold r...

Indiannica Learning is back with Indiannica Quiz League 2020 (In association with legendary quizmaster Mr Siddhartha Basu)

Indiannica Learning Private Limited a subsidiary of Navneet Education Limited is delighted to announce the launch of Indiannica Quiz League 2020, a multi-platform, mass-participative, nationwide general knowledge contest for schools. IQL i...

AgNext's AI solution for checking tea quality deployed in north-eastern states

Agri-startup AgNext on Tuesday said its artificial intelligence AI-based solution TRAGNEXT, used for determining tea quality accurately without human-intervention, has been successfully deployed in tea growing areas of north-eastern states....

Give Feedback